Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Biomerica and Bentley sign marketing and distribution agreement

Dec. 23, 1996

NIH HIV immunoassay licensed to IGEN

Dec. 23, 1996

Pharmacyclics' MRI contrast agent deemed approvable

Dec. 20, 1996

Licensees sought for MAbs specific for P-450 enzymes

Dec. 20, 1996

Licenses offered for marker in the human iNOS gene promoter region

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

Molecular Biosystems and Mallinckrodt expand contrast agent agreement

Dec. 18, 1996

Beacon obtains rights to Centocor tumor markers

Dec. 18, 1996

New imaging agents for 19F MRI claimed by Molecular Biosystems

Dec. 17, 1996

CRC and Cortecs to develop cancer diagnostic tests

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.